IDL Biotech: First step towards US

Research Note

2019-07-11

12:28

Yesterday IDL announced that a pre-submission request has been filed to FDA regarding UBC Rapid. We reiterate our forecast of a US launch in late 2022/early 2023.

LS

Ludvig Svensson

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.